The Institute for Clinical and Translational Science will host a free 5-session seminar on Systematic Literature Reviews and Meta-Analyses.
Current KL2 Scholar Brad Rosen, DO, associate in internal medicine, has been named a Harry Shwachman Clinical Investigator awardee by the Cystic Fibrosis Foundation. This prestigious award is designed to provide the opportunity for promising, clinically training physicians with a commitment to research to develop into independent cystic fibrosis (CF) biomedical researchers.
Patients with severe traumatic brain injuries have high mortality rates and poor long-term outcomes. Hyperbaric oxygen (HBO) therapy has been recognized as a possible way to offset the lack of oxygen available due to an acute brain injury by introducing supplemental HBO before cellular energy failure occurs.
Although Lanzhou, China, is about as far away from Iowa City as a person can travel — 6,975 miles, to be exact — that distance did not stop graduating senior Zhiting “Jack” Feng from traveling to the UI to study biochemistry and ethics & public policy (along with a minor in chemistry and certificate in clinical & translational science).
What do zebrafish and dance in the 1940s have in common? Both have been the objects of research by our Certificate in Clinical and Translational Science student Mikaela Mallin.
The Research Development Office, a unit of the Office of the Vice President for Research, will host a Research Services Fair on April 11, 3:00-6:00pm, in the Mediacom Outdoor Room of the Kinnick Press Box.
Once a week, Ben Schussler boards a plane and comes to UI Hospitals & Clinics for his experimental treatment for Duchenne Muscular Dystrophy (DMD). This clinical trial is testing whether a new therapy will change the progression of DMD.
Members of our Biomedical Informatics Core have been published in the Journal of Clinical and Translational Science for their research IT maturity models.
The NINDS Clinical Trials Methodology Course (CTMC) is accepting applications for the 2019 cohort. The goal of CTMC is to help investigators develop scientifically rigorous, yet practical clinical trial protocols. The focus is on investigators who have not previously designed their own prospective, interventional clinical trials.
The UI Office of the Vice President for Research and ISU’s Office of the Vice President for Research will provide seed funds to support UI and ISU researchers in developing innovative, ambitious, interdisciplinary programs that have the potential to advance both institutions’ research profiles, as well as lead to sponsored funding from government agencies, corporations, and/or foundations.